MedPath

Clinical research with cannabinoids low doses to treat Alzheimer's disease

Phase 2
Conditions
Alzheimer's disease
G00-G99
Registration Number
RBR-4cs7kjz
Lead Sponsor
niversidade Federal da Integração Latino-Americana
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

60 years old or older; to be diagnosed with Alzheimer for at least 1 year

Exclusion Criteria

to have diagnostic of other dementias or correlated diseases; família historic of psychosis; ilegal psychoactive drugs use

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath